CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 278

Industry reads hand-picked by our editors

Dec 22, 2017

Kaiser Health News
Biosimilars, biologics and new legal challenges for RA treatments
The Hill
Pharmacy benefit managers should share more drug company discounts to consumers
Bloomberg
‘I am going to die without this’: Regulators target a health-care lifesaver

Dec 21, 2017

Bloomberg
Absent from cancer drugs, Glaxo signals a revival with new hire
NBC
Millions spent by big pharma to quell talk of high drug prices
NPR
A prescription to reduce waste in health care spending
The New York Times
As overdoses mount, cities and counties rush to sue opioid makers

Dec 20, 2017

Science
Can a multibillion-dollar biotech prove its RNA drugs are safe for a rare disease?
Reuters
Gene therapy developer Orchard Therapeutics raises $110 million
Forbes
From Iran to CEO of a biotech startup, Bioniz, with no revenue but a $400 million valuation

Dec 19, 2017

Reuters
What the Gardasil testing may have missed
Reuters
Roche touts Swiss-led R&D unit after years in Genentech's shadow
Forbes
How a leading journal helped a pharma company exaggerate medication benefits

Dec 18, 2017

Bloomberg
Amazon hasn’t figured out drugstores yet. But it will have to
Reuters
Canadian police probe mysterious deaths of billionaire pharma couple
The Boston Globe
The new price of hope

Dec 15, 2017

Stat
In wake of #MeToo, a new spotlight on harassment in biomedical science
Financial Times
Pharma industry’s return on R&D investment falls sharply
Forbes
This startup has a new CRISPR enzyme -- and says it will give it away for free
Chicago Tribune
Whistleblower says she warned drugmaker of risks of taking antipsychotic Seroquel with methadone

Dec 14, 2017

Outsourcing-Pharma
Boehringer Ingelheim: Pharma cannot overcome social issues, fear, and mistrust alone
Xconomy
Kyn nabs $49M to target metabolism and beat other cancer drug combos
Scientific American
The proposed CVS–Aetna merger could threaten patient privacy

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Navigating the Impact of Claims Data Volatility on Biopharma Custom content for McKesson Compile
Infographic
Cutting Through the Chaos of Safety Letter Distribution Custom content for WCG
Playbook
How To Make the Most of Your Life Science Webinars Custom content for Cvent

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale
AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.